Anxiolytic-like activity of zinc in rodent tests

Pharmacological Reports

Volumn 63, Issue 4, 2011, Pages 1050-1055

  Partyka, Anna ^a   Jastrzȩbska Wiȩsek, Magdalena ^a   Szewczyk, Bernadeta ^b   Stachowicz, Katarzyna ^b   Sałwinśka, Anna ^b   Poleszak, Ewa ^c   Doboszewska, Urszula ^a,b   Pilc, Andrzej ^a,b   Nowak, Gabriel ^c  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

^c MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Anxiolytic activity; Elevated plus maze; Four plate test; Mice; Rats; Stress induced hyperthermia; Zinc

Indexed keywords

ZINC ASPARTATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ELEVATED PLUS MAZE TEST; EXPERIMENTAL TEST; EXPLORATORY BEHAVIOR; FOUR PLATE TEST; LOCOMOTION; MALE; MOUSE; NONHUMAN; RAT; RODENT; STRESS INDUCED HYPERTHERMIA; TRANQUILIZING ACTIVITY;

EID: 80053381955     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(11)70621-1     Document Type: Article

References (34)

1. Ahn YH, Kim YH, Hong SH, Koh JY: Depletion of intracellular zinc induces protein synthesis-dependent neuronal apoptosis in mouse cortical culture. Exp Neurol, 1998, 154, 47-56.
2. Boissier JR, Simon P, Aron C: A new method for the rapid screening of minor tranquillizers in mice. Eur J Pharmacol, 1968, 4, 145-151.
3. Bresink I, DanyszW, Parsons CG, Mutschler E: Different binding affinities of NMDAreceptor channel blockers in various brain regions - indication of NMDAreceptor heterogeneity. Neuropharmacology, 1995, 34, 533-540.
4. Brown CE, Dyck RH: Distribution of zincergic neurons in the mouse forebrain. J Comp Neurol, 2004, 479, 156-167. (Pubitemid 39314888)
5. Cichy A, Sowa-Kuæma M, Legutko B, Pomierny-Chamioło L, Siwek A, Piotrowska A, Szewczyk B et al.: Zinc-induced adaptive changes in NMDA/glutamatergic and serotonergic receptors. Pharmacol Rep, 2009, 61, 1184-1191.
6. Cieślik K, Klenk-Majewska B, Danilczuk Z, Wróbel A, Łupina T, Ossowska G: Influence of zinc supplementation on imipramine effect in chronic unpredictable stress (CUS) model in rats. Pharmacol Rep, 2007, 59, 46-52. (Pubitemid 46522701)
7. Frederickson CJ, Suh SW, Silva D, Frederickson CJ, Thompson RB: Importance of zinc in the central nervous system: the zinc-containing neuron. J Nutr, 2000, 130, 1471S-1483S. (Pubitemid 30244148)
8. Kotlinska J, Liljequist S: A characterization of anxiolytic-like actions induced by the novel NMDA/glycine site antagonist, L-701,324. Psychopharmacology, 1998, 135, 175-181. (Pubitemid 28055501)
9. Kroczka B, Brański P, Pałucha A, Pilc A, Nowak G: Antidepressant-like properties of zinc in rodent forced swim test. Brain Res Bull, 2001, 55, 297-300. (Pubitemid 32722173)
10. Lister LG: The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology, 1987, 92, 180-185.
11. Maes M, D'Haese PC, Scharpe S, D'Hondt PD, Cosyns P, De Broe ME: Hypozincemia in depression. J Affect Disord, 1994, 31, 135-140. (Pubitemid 24183901)
12. McLoughlin IJ, Hodge SJ: Zinc in depressive disorder. Acta Psychiatr Scand, 1990, 82, 451-453.
13. Nowak G, Siwek M, Dudek D, Ziȩba A, Pilc A: Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Pol J Pharmacol, 2003, 55, 1143-1147. (Pubitemid 38128954)
14. Nowak G, Szewczyk B, Pilc A: Zinc and depression. An update. Pharmacol Rep, 2005, 57, 713-718.
15. Nowak, G, Szewczyk B, Wierońska JM, Brański P, Pałucha A, Pilc A, Sadlik K, Piekoszewski W: Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res Bull, 2003, 61, 159-164. (Pubitemid 36794273)
16. OpokaW, Sowa-Kućma M, Stachowicz K, Ostachowicz B, Szlósarczyk M, Stypuła A, Młyniec K et al.: Early lifetime zinc supplementation protects zinc-deficient diet-induced alterations. Pharmacol Rep, 2010, 62, 1211-1217.
17. Paoletti P, Vergnano AM, Barbour B, Casado M: Zinc at glutamatergic synapses. Neuroscience, 2009, 158, 126-136.
18. Pellow S, File SE: Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav, 1986, 24, 525-529. (Pubitemid 16145187)
19. Plaznik A, Palejko W, Nazar M, Jessa M: Effects of antagonists at the NMDAreceptor complex in two models of anxiety. Eur Neuropsychopharmacol, 1994, 4, 503-512.
20. Rodrigues AL, Rosa AO, Lin J, Calixto JB, Santos AR: Antidepressant-like effects of zinc in mice: possible involvement of NMDA receptors and L-arginine-nitric oxide pathway. Eur Neuropsychopharmacol, 2002, 12, Suppl 3, 222.
21. A receptors in a hippocampal pathway. J Neurophysiol, 2004, 91, 1091-1096.
22. Sandstead HH, Frederickson CJ, Penland JG: History of zinc as related to brain function. J Nutr, 2000, 130, 496S-502S. (Pubitemid 30073782)
23. Siwek M, Dudek D, Paul IA, Sowa-Kućma M, Zieba A, Popik P, Pilc A, Nowak G: Zinc supplementation augments efficacy of imipramine in treatment resistant patients: A double blind, placebo-controlled study. J Affect Disord, 2009, 118, 187-95.
24. Sowa-Kućma M, Legutko B, Szewczyk B, Novak K, Znojek P, Poleszak E, Papp M et al.: Antidepressant-like activity of zinc: further behavioral and molecular evidence. J Neural Transm, 2008, 115, 1621-1628.
25. Spooren WP, Schoeffter P, Gasparini F, Kuhn R, Gentsch C: Pharmacological and endocrinological characterization of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608). Eur J Pharmacol, 2002, 435, 161-70. (Pubitemid 34131696)
26. Szewczyk B, Kubera M, Nowak G: The role of zinc in neurodegenerative inflammatory pathways in depression. Progr Neuro-Psychopharmacol Biol Psychiatry, 2011, 35, 693-701.
27. Szewczyk B, Poleszak E, Pilc A, Nowak G: Ionic glutamate modulators in depression (Zinc, Magnesium). In: Glutamate-based Therapies for Psychiatric Disorders. Ed. Skolnick P, Series: Milestones in Drug Therapy, (Parnham MJ, Bruinvels J; series editors), Springer Basel AG, 2010, 21-38.
28. Szewczyk B, Poleszak E, Sowa-Kućma M, Siwek M, Dudek D, Ryszewska-Pokraśniewicz B, Radziwoń-Zaleska M et al.: Antidepressant activity of zinc and magnesium in view of current hypotheses of antidepressant action. Pharmacol Rep, 2008, 60, 588-599.
29. Szewczyk B, Poleszak E, Wlaź P, Wróbel A, Blicharska E, Cichy A, Dybała M et al.: The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test. Prog Neuropsychopharmacol Biol Psychiatry, 2009, 33, 323-329.
30. Takeda A: Movement of zinc and its functional significance in the brain. Brain Res Rev, 2000, 34, 137-148.
31. Takeda A, Tamano H, Kan F, Itoh H, Oku N: Anxiety-like behavior of young rats after 2-week zinc deprivation. Behav Brain Res, 2007, 177, 1-6. (Pubitemid 46054205)
32. van der Heyden JAM, Zethof TJJ, Olivier B: Stress-induced hyperthermia in singly housed mice. Physiol Behav, 1997, 62, 463-470. (Pubitemid 27376279)
33. Vogt K, Mellor J, Tong G, Nicoll R: The actions of synaptically released zinc at hippocampal mossy fiber synapses. Neuron, 2000, 26, 187-196.
34. Whittle N, Lubec G, Singewald N: Zinc deficiency induces enhanced depression-like behavior and altered limbic activation reversed by antidepressant treatment in mice. Amino Acids, 2009, 36, 147-158.